News for Novo Nordisk A/S (ADR) - Google Finance

Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Hedge Funds and Insiders ...

Thu, 23 May 2013 21:41:08 GMT

Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Hedge Funds and Insiders ...
Insider Monkey (blog) - 10 hours ago

... Industries Ltd (ADR) (NYSE:TEVA). These stocks are Dr. Reddy's Laboratories Limited (ADR) (NYSE:RDY), Pharmacyclics, Inc. (NASDAQ:PCYC), Forest Laboratories, Inc. (NYSE:FRX), Novo Nordisk A/S (ADR) (NYSE:NVO), and Allergan, Inc. (NYSE:AGN).

ADR Shares End Lower Amid Disappointing Economic Data

Wed, 01 May 2013 21:21:55 GMT

ADR Shares End Lower Amid Disappointing Economic Data
Wall Street Journal - May 1, 2013

Novo Nordisk A/S (NVO, NOVO-B.KO), the world's top maker of insulin, said its hotly anticipated Tresiba drug may not hit the U.S.

Novo Nordisk Stock Rating Reaffirmed by Zacks (NVO)

Wed, 08 May 2013 02:26:08 GMT

Novo Nordisk Stock Rating Reaffirmed by Zacks (NVO)
The Utah People's Post - May 8, 2013

Zacks' analyst wrote, “Novo Nordisk posted first quarter 2013 earnings of $1.94 per ADR, up 32.5% from the year-ago period.

Novo Nordisk Given Neutral Rating at Zacks (NVO)

Wed, 24 Apr 2013 19:48:55 GMT

Novo Nordisk Given Neutral Rating at Zacks (NVO)
Daily Political - Apr 24, 2013

Novo Nordisk logo Zacks reaffirmed their neutral rating on shares of Novo Nordisk (NYSE: NVO) in a report issued on Monday, Stock Ratings Network reports.

Novo Nordisk A/S Specifies FY 2013 Sales Growth Guidance, Confirms FY 2013 Operating Profit Guidance and Lowers FY 2013 Net Income Guidance

Wed, 01 May 2013 05:30:00 GMT

Novo Nordisk A/S Specifies FY 2013 Sales Growth Guidance, Confirms FY 2013 Operating Profit Guidance and Lowers FY 2013 Net Income Guidance
Reuters Key Development - May 1, 2013

Novo Nordisk A/S Concludes Share Repurchase Program

Tue, 30 Apr 2013 12:20:00 GMT

Novo Nordisk A/S Concludes Share Repurchase Program
Reuters Key Development - Apr 30, 2013

Merrion Pharmaceuticals PLC's Partner Novo Nordisk A/S Conducts Phase I Study of NN1954-Reuters

Wed, 20 Mar 2013 09:19:00 GMT

Merrion Pharmaceuticals PLC's Partner Novo Nordisk A/S Conducts Phase I Study of NN1954-Reuters
Reuters Key Development - Mar 20, 2013

Novo Nordisk A/S Appoints Goran Ando as New Chairman

Wed, 20 Mar 2013 00:00:00 GMT

Novo Nordisk A/S Appoints Goran Ando as New Chairman
Reuters Key Development - Mar 20, 2013

Novo Nordisk A/S Announces Results from Phase 3a Clinical Trial for Liraglutide

Mon, 18 Mar 2013 11:31:00 GMT

Novo Nordisk A/S Announces Results from Phase 3a Clinical Trial for Liraglutide
Reuters Key Development - Mar 18, 2013

Novo Nordisk A/S Announces Share Repurchase Programme

Mon, 04 Mar 2013 13:21:00 GMT

Novo Nordisk A/S Announces Share Repurchase Programme
Reuters Key Development - Mar 4, 2013